Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array)
- Product No.CMB892Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length3h
- Detection Range0.1953-200pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.0651pg/mL.
- DownloadInstruction Manual
- UOM 48T96T
- FOB
US$ 559
US$ 798
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 97-104 | 101 |
| EDTA plasma(n=5) | 95-104 | 99 |
| heparin plasma(n=5) | 89-105 | 98 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 93-101% | 80-99% | 81-99% | 89-96% |
| EDTA plasma(n=5) | 80-101% | 82-93% | 90-99% | 81-92% |
| heparin plasma(n=5) | 80-99% | 82-101% | 78-90% | 82-99% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:SALa) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 50μL standard or sample to each well, add 50μL prepared Detection Reagent A, add 10μL magnetic beads, and incubate 90 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
5. Wash plate once on magnetic frame;
6. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Peptides | The bioactive peptides salusins and apelin–36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass PubMed: 22884920 |
| Department of Medical Biochemistry and Clinical Biochemistry | Presence of adropin, nesfatin-1, apelin-12, ghrelins and salusins peptides in the milk, cheese whey and plasma of dairy cows ScienceDirect: S0196978113000533 |
| European Journal of Obstetrics & Gynecology and Reproductive Biology | Association of low maternal levels of salusins with gestational diabetes mellitus and with small-for-gestational-age fetuses. PubMed: 23178004 |
| Biotechnic & Histochemistry | Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome Pubmed: 23957705 |
| Peptides | Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitus ScienceDirect: S0196978113003100 |
| Med Sci Monit. | Brain, Liver, and Serum Salusin-alpha and-beta Alterations in Sprague-Dawley Rats with or Without Metabolic Syndrome Pubmed:Pmc4136931 |
| Pediatr Nephrol. | Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population? Pubmed:25245503 |
| European Journal of Dermatology | Serum salusin-α and salusin-β levels in patients with psoriasis PubMed: 26055619 |
| Gynecol Endocrinol | Serum salusins levels are increased and correlated positively with cyst size in ovarian endometrioma PubMed: 26008602 |
| Multiple Sclerosis and Related Disorders | Increased level of Plasma Salusin-α and Salusin-β in patients with Multiple Sclerosis Pubmed: 30738876 |
| cardiology in the young | Salusin-α levels are negatively correlated with diastolic blood pressure in children with obesity Pubmed: 31486354 |
| Drug and Chemical Toxicology | Salusin-α mitigates diabetic nephropathy via inhibition of the Akt/mTORC1/p70S6K signaling pathway in diabetic rats Pubmed: 31665937 |
| Journal of international medical research | Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis Pubmed: 32054363 |
| J Ultrasound Med | Targeted Delivery of Salusin©\¦Á into Rabbit Carotid Arterial Endothelium Using SonoVue 33818784 |
| Food Science & Nutrition | Inhibition of oxidative stress and apoptosis by camel milk mitigates cyclosporine©\induced nephrotoxicity: Targeting Nrf2/HO©\1 and AKT/eNOS/NO pathways 34136182 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPB892Hu01 | Recombinant Salusin Alpha (SALa) | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPB892Hu11 | BSA Conjugated Salusin Alpha (SALa) | Immunogen; SDS-PAGE; WB. |
| CPB892Hu21 | OVA Conjugated Salusin Alpha (SALa) | Immunogen; SDS-PAGE; WB. |
| PAB892Hu01 | Polyclonal Antibody to Salusin Alpha (SALa) | WB; IHC; ICC; IP. |
| PAB892Hu08 | Polyclonal Antibody to Salusin Alpha (SALa) | WB; IHC; ICC; IP. |
| CEB892Hu | ELISA Kit for Salusin Alpha (SALa) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CMB892Hu | Multiplex Assay Kit for Salusin Alpha (SALa) ,etc. by CBA (Cytometric Bead Array) | FLIA Kit for Antigen Detection. |
| LMB892Hu | Multiplex Assay Kit for Salusin Alpha (SALa) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
| KSB892Hu11 | ELISA Kit DIY Materials for Salusin Alpha (SALa) | Main materials for "Do It (ELISA Kit) Yourself". |

